Dr. Amy Shaw, MD

NPI: 1427127588
Total Payments
$112,442
2024 Payments
$14,786
Companies
41
Transactions
451
Medicare Patients
4,783
Medicare Billing
$4.6M

Payment Breakdown by Category

Other$92,779 (82.5%)
Travel$10,749 (9.6%)
Food & Beverage$8,763 (7.8%)
Education$151.28 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $92,779 64 82.5%
Travel and Lodging $10,749 58 9.6%
Food and Beverage $8,763 317 7.8%
Education $151.28 12 0.1%

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $108,095 264 $0 (2024)
Radius Health, Inc. $379.43 10 $0 (2023)
AstraZeneca Pharmaceuticals LP $344.90 16 $0 (2024)
Seagen Inc. $253.14 10 $0 (2023)
Novartis Pharmaceuticals Corporation $244.84 11 $0 (2023)
PFIZER INC. $212.65 10 $0 (2024)
Merck Sharp & Dohme Corporation $201.32 11 $0 (2021)
Incyte Corporation $186.91 10 $0 (2022)
EISAI INC. $185.58 9 $0 (2022)
Alexion Pharmaceuticals, Inc. $185.42 7 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $14,786 44 Amgen Inc. ($14,408)
2023 $6,617 50 Amgen Inc. ($5,853)
2022 $11,488 63 Amgen Inc. ($10,879)
2021 $9,136 48 Amgen Inc. ($8,678)
2020 $11,121 54 Amgen Inc. ($10,636)
2019 $47,514 112 Amgen Inc. ($46,903)
2018 $11,257 54 Amgen Inc. ($10,579)
2017 $524.87 26 Amgen Inc. ($158.44)

All Payment Transactions

451 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
12/20/2024 Amgen Inc. EVENITY (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $574.50 General
Category: Bone Health
11/25/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $12.12 General
Category: Bone Health
11/19/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $25.08 General
Category: ONCOLOGY
11/11/2024 Amgen Inc. EVENITY (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,300.00 General
Category: Bone Health
11/06/2024 Amgen Inc. EVENITY (Biological) Food and Beverage In-kind items and services $107.70 General
Category: Bone Health
10/28/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $26.26 General
Category: Oncology
10/22/2024 Amgen Inc. EVENITY (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,300.00 General
Category: Bone Health
10/21/2024 GlaxoSmithKline, LLC. OJJAARA (Drug) Food and Beverage In-kind items and services $23.81 General
Category: ONCOLOGY
10/17/2024 Amgen Inc. EVENITY (Biological) Food and Beverage In-kind items and services $103.01 General
Category: Bone Health
10/16/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $11.99 General
Category: Bone Health
09/17/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $36.20 General
Category: ONCOLOGY
09/09/2024 Amgen Inc. EVENITY (Biological) Travel and Lodging Cash or cash equivalent $28.14 General
Category: Bone Health
08/28/2024 Amgen Inc. EVENITY (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,300.00 General
Category: Bone Health
08/27/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $23.53 General
Category: ONCOLOGY
08/22/2024 Amgen Inc. EVENITY (Biological) Food and Beverage In-kind items and services $22.63 General
Category: Bone Health
08/20/2024 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $37.97 General
Category: ONCOLOGY
07/23/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $14.30 General
Category: ONCOLOGY
07/12/2024 Amgen Inc. EVENITY (Biological) Travel and Lodging Cash or cash equivalent $184.74 General
Category: Bone Health
07/12/2024 Amgen Inc. EVENITY (Biological) Travel and Lodging Cash or cash equivalent $152.76 General
Category: Bone Health
07/12/2024 Amgen Inc. EVENITY (Biological) Food and Beverage Cash or cash equivalent $25.00 General
Category: Bone Health
07/12/2024 Amgen Inc. EVENITY (Biological) Travel and Lodging Cash or cash equivalent $15.00 General
Category: Bone Health
07/10/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $13.38 General
Category: Bone Health
07/09/2024 PFIZER INC. IBRANCE (Drug), TUKYSA Food and Beverage In-kind items and services $31.06 General
Category: ONCOLOGY
06/27/2024 Amgen Inc. EVENITY (Biological) Travel and Lodging Cash or cash equivalent $124.62 General
Category: Bone Health
06/19/2024 Amgen Inc. EVENITY (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,300.00 General
Category: Bone Health

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 1,592 171,097 $4.6M $1.7M
2022 9 1,233 148,575 $3.4M $1.4M
2021 8 1,036 88,369 $1.4M $868,819
2020 8 922 53,380 $1.0M $561,654
Total Patients
4,783
Total Services
461,421
Medicare Billing
$4.6M
Procedure Codes
36

All Medicare Procedures & Services

36 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J3111 Injection, romosozumab-aqqg, 1 mg Office 2023 119 143,116 $3.3M $1.1M 34.3%
J0897 Injection, denosumab, 1 mg Office 2023 243 25,680 $873,120 $471,139 54.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 482 700 $241,500 $69,386 28.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 138 138 $81,558 $23,508 28.8%
96372 Injection of drug or substance under skin or into muscle Office 2023 335 1,158 $45,162 $14,368 31.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 133 148 $36,260 $10,113 27.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 59 69 $33,465 $9,905 29.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 11 11 $4,917 $1,569 31.9%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 16 19 $4,655 $1,488 32.0%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2023 39 41 $2,665 $802.71 30.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 17 17 $2,618 $794.40 30.3%
J3111 Injection, romosozumab-aqqg, 1 mg Office 2022 87 125,790 $2.3M $931,753 40.6%
J0897 Injection, denosumab, 1 mg Office 2022 201 20,940 $711,960 $355,706 50.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 385 552 $190,440 $56,113 29.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 109 109 $64,419 $19,021 29.5%
96372 Injection of drug or substance under skin or into muscle Office 2022 262 981 $38,259 $12,677 33.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 45 48 $23,280 $7,020 30.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 99 108 $26,460 $6,978 26.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 18 18 $8,046 $2,243 27.9%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2022 27 29 $1,885 $618.72 32.8%
J3111 Injection, romosozumab-aqqg, 1 mg Office 2021 54 70,351 $633,159 $503,015 79.4%
J0897 Injection, denosumab, 1 mg Office 2021 151 16,320 $554,880 $263,809 47.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 400 576 $112,320 $60,421 53.8%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 72 72 $26,712 $13,333 49.9%
96372 Injection beneath the skin or into muscle for therapy, diagnosis, or prevention Office 2021 190 866 $43,300 $10,744 24.8%

About Dr. Amy Shaw, MD

Dr. Amy Shaw, MD is a Family Medicine healthcare provider based in Santa Rosa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427127588.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Shaw, MD has received a total of $112,442 in payments from pharmaceutical and medical device companies, with $14,786 received in 2024. These payments were reported across 451 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($92,779).

As a Medicare-enrolled provider, Shaw has provided services to 4,783 Medicare beneficiaries, totaling 461,421 services with total Medicare billing of $4.6M. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Santa Rosa, CA
  • Active Since 11/06/2006
  • Last Updated 11/10/2021
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1427127588

Products in Payments

  • EVENITY (Biological) $54,709
  • Prolia (Biological) $52,973
  • Tymlos (Biological) $332.21
  • LIBTAYO (Biological) $205.90
  • Enhertu (Drug) $182.42
  • LYNPARZA (Drug) $182.19
  • KEYTRUDA (Biological) $164.59
  • JAKAFI (Drug) $127.60
  • JEVTANA (Drug) $126.11
  • Halaven (Drug) $123.68
  • Osphena (Drug) $119.37
  • Cabometyx (Drug) $118.76
  • SOLIRIS (Drug) $113.59
  • TUKYSA (Drug) $105.00
  • VERZENIO (Drug) $104.87
  • IBRANCE (Drug) $99.84
  • ADCETRIS (Biological) $90.78
  • Kyprolis (Drug) $88.64
  • FOUNDATIONONE (Device) $87.89
  • ENHERTU (Biological) $87.17

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Santa Rosa